Flunarizine Hydrochloride

盐酸氟桂利嗪

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameFlunarizine Hydrochloride
Drug Alias Nameflunarizinum盐酸氟桂嗪盐酸氟苯桂嗪flunarizineflunarizina +[8] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVoltage-gated calcium channel blockers
TargetsVoltage-gated calcium channel
Therapy Area/IndicationsMigraine without AuraMigraine DisordersEpilepsy, Absence +[6] 
Global Approved IndicationsMigraine DisordersVertigo
Approved Indications in ChinaMigraine DisordersVertigo
Original Approved Country/TerritoryMainland China
Original Approved Date1990/01/01
Country/TerritoryCanadaMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesGuangzhou University Of Chinese MedicineHenan Xichuan County Fusen Pharmaceutical Co Ltd
Inactive CompaniesThe University Of British Columbia
Active IndicationsMigraine without AuraMigraine DisordersVertigo
Inactive IndicationsEpilepsy, AbsenceMyoclonic Epilepsy, JuvenileEpilepsy

Other Information

ATC CodeN07CA03
Related LinksWikipediaDrugBankKEGG